GMP Grade and fit-for-purpose reagents for manufacturing of mRNA therapeutics
After decades of development, mRNA therapeutics were propelled into the global spotlight by the SARS-CoV-2 pandemic. From vaccines and immunotherapies to protein replacement and cell reprogramming, interest in mRNA manufacturing has surged. This creates immense opportunity, but also growing competition and evolving regulations.
To lead in this fast-paced environment, breakthrough science is not enough. Success hinges on development speed and uncompromising product safety.
As a long-standing global supplier of raw materials our expertise is providing the foundation to scale your ideas. We help you strengthen your supply chain, ease transfers to manufacturing, secure continuous production, and create consistently high-quality products.
